• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Unq2015Jan

Motion Equity Partners acquires CDL

GP back on the investment front

  • France
  • 20 November 2014
EdRip, BPI France invest in Finsecur

Fresh capital to be used for new product research and development

  • France
  • 18 November 2014
Lloyds hires head of UK funds
Lloyds hires head of UK funds

Zhao previously worked at Erste, Citigroup, Deutsche Bank and Deloitte

  • People
  • 18 November 2014
Gimv acquires EcoChem

EcoChem's founders and other shareholders reinvested for minority stake

  • Benelux
  • 13 November 2014
Enterprise Investors lists Skarbiec

IPO generates proceeds of €10.2m

  • CEE
  • 13 November 2014
Parter Capital injects CHF 4.5m into Histide

Private equity house specialises in research-based investments

  • DACH
  • 11 November 2014
Hellman & Friedman hits $10.9bn for eighth fund

GP contributed $500m to the fund

  • Buyout
  • 10 November 2014
Waterland sells Omega for €3.6bn

Deal values Omega's equity at €2.48bn

  • Benelux
  • 07 November 2014
BayBG backs Eyeglass24

Online lens seller reaps more than €1m in second funding round this year

  • DACH
  • 07 November 2014
Co-investments demand balance of power – Nick Money-Kyrle
Co-investments demand balance of power – Nick Money-Kyrle

As LPs continue to demand co-investments, unquote" finds out what GPs really think of these deals

  • Investments
  • 07 November 2014
Carlyle et al. buy Dealogic for $700m

Consortium of investors acquires Dealogic as well as two related joint ventures

  • Buyouts
  • 06 November 2014
Molecular Partners to raise CHF 96m after IPO delay

Offering will give company a market cap of CHF 485m

  • DACH
  • 04 November 2014
Sunstone et al. sell Galecto for $444m

Bristol-Myers Squibb signs option to buy company within 60 days of successful clinical trials

  • Nordics
  • 04 November 2014
Probiodrug raises €22.5m in Euronext IPO

Fresh capital to be used for advancing development of Alzheimer's drug

  • DACH
  • 03 November 2014
SL Capital hires two
SL Capital hires two

Kellermann becomes new head of DACH

  • People
  • 03 November 2014
Altium's Hinderer steps down

Altium managing director and board member Hinderer is stepping down

  • People
  • 30 October 2014
12
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013